[Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
Heilig
Markus
M
markus.heilig@neurotec.ki.se
D018849:Controlled Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D015201:Meta-Analysis as Topic; D008691:Methadone / Q000008:administration & dosage*; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009294:Narcotics / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D009292:Narcotic Antagonists; D009294:Narcotics; D009271:Naltrexone; D008691:Methadone